Paid Clinical Trials in Mineola, NY
As of September 2026, 113 paid clinical trials are recruiting in Mineola, New York. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Mineola offers studies at sites including NYU Langone Hospital - Long Island for conditions such as Breast Cancer, Multiple Myeloma, Anatomic Stage II Breast Cancer AJCC v8, Endometrial Cancer. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Mineola
Trials by drug in Mineola
Filter results
Newly added in Mineola
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
110 clinical trials
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
Pan Tumor Rollover Study
The PREDICT Registry:
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03)
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
PARTNER 3 Trial - Aortic Valve-in-Valve
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease
A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib as a Single Agent or in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation
Top Research Study Locations in Mineola
Researchers run research studies in Mineola, NY at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| NYU Langone Hospital - Long Island | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 | 51 |
| Perlmutter Cancer Center at NYU Langone Hospital - Long Island | Neoplasm Metastasis, Advanced Breast Cancer, Advanced Solid Tumor | 12 |
| Laura & Isaac Perlmutter Cancer Center at NYU Langone Hospital - Long Island | Carcinoma, Non-Small-Cell Lung, Metastatic Castration-resistant Prostate Neoplasms, Metastatic Hormone-sensitive Prostate Cancer | 5 |
| NYU Langone Health | Acneiform Eruption Due to Chemical, Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation, Advanced Ovarian Carcinoma | 4 |
| NYU Langone Health - Long Island | Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms, Endometrial Neoplasms | 3 |
| NYU Langone Hospital Long Island | Metastatic Castration-resistant Prostatic Neoplasms, Multiple Myeloma, Non Small Cell Lung Cancer (Squamous or Non Squamous) | 3 |
| NYU Langone Hospital-Long Island | Breast Cancer, Pressure Ulcer, Stage IV, Pressure Ulcers Stage II | 2 |
| NYU Langone Nephrology Associates-Mineola | Focal Segmental Glomerulosclerosis, Proteinuric Kidney Diseases | 2 |
| New York University Langone Hospital - Long Island | Acute Myeloid Leukemia, Breast Cancer, Chronic Myelomonocytic Leukemia | 2 |
| Perlmutter Cancer Center at NYU Long Island | Colorectal Neoplasms | 2 |
| Winthrop University Hospital | Aortic Stenosis, Aortic Stenosis, Severe, Bladder Cancer | 2 |
| Clinical Study Site | Metastatic Colorectal Cancer (CRC) | 1 |
| Clinical Trial Site | Hypophosphatasia | 1 |
| Day Op Center of Long Island | Lumbar Spinal Stenosis | 1 |
| GSK Investigational Site | Neoplasms, Solid Tumors | 1 |
| Laura and Isaac Perlmutter Cancer Center at NYU Langone | Untreated, Unresectable, or Metastatic Colorectal Cancer | 1 |
| Local Institution - 0100 | Hepatocellular Carcinoma (HCC) | 1 |
| NYU - Long Island | DCIS, Ductal Breast Carcinoma In Situ, Stage 0 Breast Cancer | 1 |
| NYU Langone Health Long Island | Castration Resistant Prostatic Cancer, Metastatic Castration-resistant Prostate Cancer, Prostate Cancer | 1 |
| NYU Langone Health Long Island - Research & Academic Center | Venous Leg Ulcer (VLU) | 1 |
| NYU Langone Hematology Oncology Associates-Mineola | Cancer | 1 |
| NYU Langone Hospital - Long Island Clinical Research Center | Osteomyelitis, Pressure Ulcer, Stage IV | 1 |
| NYU Langone Hospital - Long Island Investigational Pharmacy | Biliary Tract Cancer, Breast Cancer, Cervical Cancer | 1 |
| NYU Langone Hospital-Long Island (Winthrop) | Lumbar Spinal Stenosis | 1 |
| NYU Langone Long Island, Clinical Research Center 3-002 (Admin only) | Healthy | 1 |
Active & Upcoming Studies in Mineola (2026)
Recruiting trials in Mineola grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (76 active studies)
- Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial · Phase 3 · National Cancer Institute (NCI)
- A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer. · Phase 2, Phase 3 · Eikon Therapeutics
Diabetes & metabolic (1 active study)
Neurology & pain (1 active study)
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO · Phase 1 · National Cancer Institute (NCI)
Cardiovascular (1 active study)
Common conditions studied in Mineola
- Breast Cancer (5 active studies)
- Multiple Myeloma (5 active studies)
- Anatomic Stage II Breast Cancer AJCC v8 (4 active studies)
- Endometrial Cancer (4 active studies)
- Acute Myeloid Leukemia (3 active studies)
- Anatomic Stage III Breast Cancer AJCC v8 (3 active studies)
Leading research sponsors in Mineola
- National Cancer Institute (NCI)
- Janssen Research & Development, LLC
- Merck Sharp & Dohme LLC
- NRG Oncology
- Children's Oncology Group
Frequently asked questions
How many paid clinical trials are currently recruiting in Mineola?
There are approximately 113 recruiting clinical trials in Mineola, New York listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Mineola pay participants?
Most recruiting trials in Mineola compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Mineola?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Mineola?
The most common conditions under active study in Mineola include Breast Cancer (5), Multiple Myeloma (5), Anatomic Stage II Breast Cancer AJCC v8 (4), Endometrial Cancer (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Mineola?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Mineola on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Mineola?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Mineola?
Recruiting research sites in Mineola include NYU Langone Hospital - Long Island, Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Laura & Isaac Perlmutter Cancer Center at NYU Langone Hospital - Long Island, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Mineola right now?
The largest active categories in Mineola are Cancer & tumors (76), Diabetes & metabolic (1), Neurology & pain (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.